Oral Dosage Form New Animal Drugs; Change of Sponsor; Lincomycin Hydrochloride Soluble Powder; Penicillin G Potassium in Drinking Water; Tetracycline Powder, 20987-20988 [2012-8322]
Download as PDF
20987
Rules and Regulations
Federal Register
Vol. 77, No. 68
Monday, April 9, 2012
This section of the FEDERAL REGISTER
contains regulatory documents having general
applicability and legal effect, most of which
are keyed to and codified in the Code of
Federal Regulations, which is published under
50 titles pursuant to 44 U.S.C. 1510.
The Code of Federal Regulations is sold by
the Superintendent of Documents. Prices of
new books are listed in the first FEDERAL
REGISTER issue of each week.
DEPARTMENT OF TRANSPORTATION
Federal Aviation Administration
14 CFR Part 39
[Docket No. FAA–2011–0959; Directorate
Identifier 2011–NE–25–AD; Amendment 39–
16970; AD 2012–04–14]
RIN 2120–AA64
Airworthiness Directives; Rolls-Royce
plc Turbofan Engines
Federal Aviation
Administration (FAA), DOT.
ACTION: Final rule; correction.
AGENCY:
The FAA is correcting an
airworthiness directive (AD) that
published in the Federal Register. That
AD applies to RB211–Trent 800 series
turbofan engines. The last comment
response in the preamble and the first
sentence of regulatory text paragraph
(g)(1) are incorrect. The repetitive
inspection interval should be 2,000
flight cycles, not 1,000 flight cycles.
This document corrects those errors. In
all other respects, the original document
remains the same.
DATES: This final rule is effective April
11, 2012.
ADDRESSES: You may examine the AD
docket on the Internet at https://
www.regulations.gov; or in person at the
Docket Management Facility between 9
a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The AD
docket contains this AD, the regulatory
evaluation, any comments received, and
other information. The address for the
Docket Office (phone: 800–647–5527) is
Document Management Facility, U.S.
Department of Transportation, Docket
Operations, M–30, West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue SE., Washington,
DC 20590.
FOR FURTHER INFORMATION CONTACT:
Alan Strom, Aerospace Engineer, Engine
pmangrum on DSK3VPTVN1PROD with RULES
SUMMARY:
VerDate Mar<15>2010
14:49 Apr 06, 2012
Jkt 226001
Certification Office, FAA, Engine &
Propeller Directorate, 12 New England
Executive Park, Burlington, MA 01803;
email: alan.strom@faa.gov; phone: 781–
238–7143; fax: 781–238–7199.
SUPPLEMENTARY INFORMATION: AD 2012–
04–14, Amendment 39–16970 (77 FR
13485, March 7, 2012), currently
requires inspecting the front combustion
liner head section for cracking, and if
found cracked, removing the front
combustion liner head section from
service at the next shop visit.
As published, the last comment
response in the preamble, and the first
sentence of regulatory text paragraph
(g)(1), are incorrect. No other part of the
preamble or regulatory text has been
changed; therefore, only the changed
portions of the final rule is being
published in the Federal Register.
The effective date of this AD remains
April 11, 2012.
Correction of Non-Regulatory Text
In the Federal Register of March 7,
2012, AD 2012–04–14; Amendment 39–
16970, is corrected to read as follows:
On page 13486, in the 3rd column,
under the heading Need to Show All
Acceptable Means of Completing the
On-Wing Inspection, the 2nd sentence
in the 1st paragraph is corrected to read
‘‘We changed the 2nd sentence of
paragraphs (f)(1) and (g)(1) of the
proposed AD from:’’
On page 13486, in the 3rd column,
under the heading Need to Show All
Acceptable Means of Completing the
On-Wing Inspection, the 1st sentence in
the 2nd and 3rd paragraphs, is deleted.
Correction of Regulatory Text
§ 39.13
[Corrected]
In the Federal Register of March 7,
2012, AD 2012–04–14; Amendment 39–
16970, on page 13487, in the first
column, in paragraph (g)(1), the first
sentence is corrected to read as follows:
*
*
*
*
*
(g)(1) At intervals not to exceed 2,000
FCs, inspect the front combustion liner
head section for cracking.
*
*
*
*
*
■
Issued in Burlington, Massachusetts, on
March 30, 2012.
Colleen D’Alessandro,
Assistant Manager, Engine & Propeller
Directorate, Aircraft Certification Service.
[FR Doc. 2012–8289 Filed 4–6–12; 8:45 am]
BILLING CODE 4910–13–P
PO 00000
Frm 00001
Fmt 4700
Sfmt 4700
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520
[Docket No. FDA–2012–N–0002]
Oral Dosage Form New Animal Drugs;
Change of Sponsor; Lincomycin
Hydrochloride Soluble Powder;
Penicillin G Potassium in Drinking
Water; Tetracycline Powder
AGENCY:
Food and Drug Administration,
HHS.
Final rule; technical
amendment.
ACTION:
The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect a
change of sponsor for three abbreviated
new animal drug applications
(ANADAs) for lincomycin
hydrochloride; penicillin G potassium,
USP; and tetracycline hydrochloride
soluble powders administered in
drinking water from Teva Animal
Health, Inc., to Quo Vademus, LLC.
DATES: This rule is effective April 9,
2012.
FOR FURTHER INFORMATION CONTACT:
Steven D. Vaughn, Center for Veterinary
Medicine (HFV–100), Food and Drug
Administration, 7520 Standish Pl.,
Rockville, MD 20855, 240–276–8300,
email: steven.vaughn@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Teva
Animal Health, Inc., 3915 South 48th
Street Ter., St. Joseph, MO 64503, has
informed FDA that it has transferred
ownership of, and all rights and interest
in, ANADA 200–136 for Tetracycline
Hydrochloride Soluble Powder 324;
ANADA 200–303 for Lincomycin
Hydrochloride Soluble Powder; and
ANADA 200–347 for Penicillin G
Potassium, USP, all soluble powders
administered in drinking water to Quo
Vademus, LLC, 277 Faison West
McGowan Rd., Kenansville, NC 28349.
Accordingly, the Agency is amending
the regulations in part 520 (21 CFR part
520) to reflect the transfer of ownership
and a current format.
In addition FDA has noticed two
errors in § 520.1696 Penicillin oral
dosage forms. At this time, § 520.1696a
is being removed because no sponsor is
listed, and an obsolete drug labeler code
is being removed from § 520.1696d.
SUMMARY:
E:\FR\FM\09APR1.SGM
09APR1
20988
Federal Register / Vol. 77, No. 68 / Monday, April 9, 2012 / Rules and Regulations
These actions are being taken to
improve the accuracy of the regulations.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
List of Subjects in 21 CFR Part 520
Animal drugs.
Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 520 is amended as follows:
8. In § 520.1696d, revise the section
heading and paragraph (b) and remove
and reserve paragraph (c) to read as
follows:
■
§ 520.1696d
*
*
*
*
(b) Sponsors. See Nos. 050604 and
053501 in § 510.600(c) of this chapter.
*
*
*
*
*
9. In § 520.2345, revise the section
heading to read as follows:
■
Tetracycline.
*
SUMMARY:
*
*
*
2. In § 520.1263, revise the section
heading to read as follows:
§ 520.1263
Lincomycin.
*
*
*
*
*
■ 3. In § 520.1263c, revise the section
heading and paragraph (b) to read as
follows:
§ 520.1263c
Dated: March 27, 2012.
William T. Flynn,
Acting Director, Center for Veterinary
Medicine.
Lincomycin powder.
[FR Doc. 2012–8322 Filed 4–6–12; 8:45 am]
*
*
*
*
*
(b) Sponsors. See Nos. 000009,
046573, 054925, 061623, and 076475 in
§ 510.600(c) of this chapter for use as in
paragraph (d) of this section.
*
*
*
*
*
■ 4. In § 520.1696, revise the section
heading to read as follows:
§ 520.1696
*
*
§ 520.1696a
*
*
5. Remove and reserve § 520.1696a.
■ 6. In § 520.1696b, revise the section
heading, paragraphs (a) and (b), and the
heading for paragraph (c) to read as
follows:
■
pmangrum on DSK3VPTVN1PROD with RULES
Penicillin G powder.
(a) Specifications. Each gram of
powder contains penicillin G potassium
equivalent to 1.54 million units of
penicillin G.
(b) Sponsors. See Nos. 010515,
046573, 053501, 059320, 061623 and
076475 in § 510.600(c) of this chapter.
(c) Conditions of use in turkeys—
*
*
*
*
*
■ 7. In § 520.1696c, revise the section
heading and remove and reserve
paragraph (c) to read as follows:
§ 520.1696c
*
*
Penicillin V powder.
*
VerDate Mar<15>2010
*
LIBRARY OF CONGRESS
Copyright Office
[Docket No. 2011–8]
[Removed and Reserved]
§ 520.1696b
BILLING CODE 4160–01–P
37 CFR Parts 201 and 202
Penicillin.
*
Tetracycline powder.
*
*
*
*
(b) * * *
(4) Nos. 054925, 057561, 061623, and
076475: 324 grams per pound as in
paragraph (d) of this section.
*
*
*
*
*
Authority: 21 U.S.C. 360b.
Discontinuance of Form CO in
Registration Practices
Correction
In rule document 2012–7429
appearing on pages 18705–18707 in the
issue of March 28, 2012, make the
following corrections:
1. On page 18706, in the third
column, in the 17th line from the
bottom, ‘‘b.’’ should read ‘‘Å.’’.
§ 202.2
[Corrected]
2. On page 18707, in § 202.2, in the
first column, in amendatory instruction
4, in the third line, ‘‘b’’ should read
‘‘Å’’.
■
[FR Doc. C1–2012–7429 Filed 4–6–12; 8:45 am]
BILLING CODE 1505–01–D
*
16:35 Apr 06, 2012
Jkt 226001
Suspension of Community Eligibility
*
*
■
[Docket ID FEMA–2012–0003; Internal
Agency Docket No. FEMA–8225]
§ 520.2345
§ 520.2345d
1. The authority citation for 21 CFR
part 520 continues to read as follows:
44 CFR Part 64
Federal Emergency
Management Agency, DHS.
ACTION: Final rule.
10. In § 520.2345d, revise paragraph
(b)(4) to read as follows:
■
Federal Emergency Management
Agency
Penicillin V tablets.
*
■
PART 520—ORAL DOSAGE FORM
NEW ANIMAL DRUGS
DEPARTMENT OF HOMELAND
SECURITY
PO 00000
Frm 00002
Fmt 4700
Sfmt 4700
AGENCY:
This rule identifies
communities where the sale of flood
insurance has been authorized under
the National Flood Insurance Program
(NFIP) that are scheduled for
suspension on the effective dates listed
within this rule because of
noncompliance with the floodplain
management requirements of the
program. If the Federal Emergency
Management Agency (FEMA) receives
documentation that the community has
adopted the required floodplain
management measures prior to the
effective suspension date given in this
rule, the suspension will not occur and
a notice of this will be provided by
publication in the Federal Register on a
subsequent date.
DATES: The effective date of each
community’s scheduled suspension is
the third date (‘‘Susp.’’) listed in the
third column of the following tables.
FOR FURTHER INFORMATION CONTACT: If
you want to determine whether a
particular community was suspended
on the suspension date or for further
information, contact David Stearrett,
Federal Insurance and Mitigation
Administration, Federal Emergency
Management Agency, 500 C Street SW.,
Washington, DC 20472, (202) 646–2953.
SUPPLEMENTARY INFORMATION: The NFIP
enables property owners to purchase
Federal flood insurance that is not
otherwise generally available from
private insurers. In return, communities
agree to adopt and administer local
floodplain management aimed at
protecting lives and new construction
from future flooding. Section 1315 of
the National Flood Insurance Act of
1968, as amended, 42 U.S.C. 4022,
prohibits the sale of NFIP flood
insurance unless an appropriate public
body adopts adequate floodplain
management measures with effective
enforcement measures. The
communities listed in this document no
longer meet that statutory requirement
for compliance with program
regulations, 44 CFR part 59.
E:\FR\FM\09APR1.SGM
09APR1
Agencies
[Federal Register Volume 77, Number 68 (Monday, April 9, 2012)]
[Rules and Regulations]
[Pages 20987-20988]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8322]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520
[Docket No. FDA-2012-N-0002]
Oral Dosage Form New Animal Drugs; Change of Sponsor; Lincomycin
Hydrochloride Soluble Powder; Penicillin G Potassium in Drinking Water;
Tetracycline Powder
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; technical amendment.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor for three abbreviated
new animal drug applications (ANADAs) for lincomycin hydrochloride;
penicillin G potassium, USP; and tetracycline hydrochloride soluble
powders administered in drinking water from Teva Animal Health, Inc.,
to Quo Vademus, LLC.
DATES: This rule is effective April 9, 2012.
FOR FURTHER INFORMATION CONTACT: Steven D. Vaughn, Center for
Veterinary Medicine (HFV-100), Food and Drug Administration, 7520
Standish Pl., Rockville, MD 20855, 240-276-8300, email:
steven.vaughn@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Teva Animal Health, Inc., 3915 South 48th
Street Ter., St. Joseph, MO 64503, has informed FDA that it has
transferred ownership of, and all rights and interest in, ANADA 200-136
for Tetracycline Hydrochloride Soluble Powder 324; ANADA 200-303 for
Lincomycin Hydrochloride Soluble Powder; and ANADA 200-347 for
Penicillin G Potassium, USP, all soluble powders administered in
drinking water to Quo Vademus, LLC, 277 Faison West McGowan Rd.,
Kenansville, NC 28349. Accordingly, the Agency is amending the
regulations in part 520 (21 CFR part 520) to reflect the transfer of
ownership and a current format.
In addition FDA has noticed two errors in Sec. 520.1696 Penicillin
oral dosage forms. At this time, Sec. 520.1696a is being removed
because no sponsor is listed, and an obsolete drug labeler code is
being removed from Sec. 520.1696d.
[[Page 20988]]
These actions are being taken to improve the accuracy of the
regulations.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 520
Animal drugs.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is
amended as follows:
PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
0
1. The authority citation for 21 CFR part 520 continues to read as
follows:
Authority: 21 U.S.C. 360b.
0
2. In Sec. 520.1263, revise the section heading to read as follows:
Sec. 520.1263 Lincomycin.
* * * * *
0
3. In Sec. 520.1263c, revise the section heading and paragraph (b) to
read as follows:
Sec. 520.1263c Lincomycin powder.
* * * * *
(b) Sponsors. See Nos. 000009, 046573, 054925, 061623, and 076475
in Sec. 510.600(c) of this chapter for use as in paragraph (d) of this
section.
* * * * *
0
4. In Sec. 520.1696, revise the section heading to read as follows:
Sec. 520.1696 Penicillin.
* * * * *
Sec. 520.1696a [Removed and Reserved]
0
5. Remove and reserve Sec. 520.1696a.
0
6. In Sec. 520.1696b, revise the section heading, paragraphs (a) and
(b), and the heading for paragraph (c) to read as follows:
Sec. 520.1696b Penicillin G powder.
(a) Specifications. Each gram of powder contains penicillin G
potassium equivalent to 1.54 million units of penicillin G.
(b) Sponsors. See Nos. 010515, 046573, 053501, 059320, 061623 and
076475 in Sec. 510.600(c) of this chapter.
(c) Conditions of use in turkeys--
* * * * *
0
7. In Sec. 520.1696c, revise the section heading and remove and
reserve paragraph (c) to read as follows:
Sec. 520.1696c Penicillin V powder.
* * * * *
0
8. In Sec. 520.1696d, revise the section heading and paragraph (b) and
remove and reserve paragraph (c) to read as follows:
Sec. 520.1696d Penicillin V tablets.
* * * * *
(b) Sponsors. See Nos. 050604 and 053501 in Sec. 510.600(c) of
this chapter.
* * * * *
0
9. In Sec. 520.2345, revise the section heading to read as follows:
Sec. 520.2345 Tetracycline.
* * * * *
0
10. In Sec. 520.2345d, revise paragraph (b)(4) to read as follows:
Sec. 520.2345d Tetracycline powder.
* * * * *
(b) * * *
(4) Nos. 054925, 057561, 061623, and 076475: 324 grams per pound as
in paragraph (d) of this section.
* * * * *
Dated: March 27, 2012.
William T. Flynn,
Acting Director, Center for Veterinary Medicine.
[FR Doc. 2012-8322 Filed 4-6-12; 8:45 am]
BILLING CODE 4160-01-P